Loading...
Market
Which subtype of Parkinson's Disease identified in the study will be the focus of the first new drug development by the end of 2024?
2
Resolution / Starting Odds
Subtype 1 • 33%
Subtype 2 • 33%
Subtype 3 • 33%
Other • 1%
Pharmaceutical company announcements, clinical trial registries, or medical journals
Story
AI Identifies New Parkinson's Subtypes and Analyzes 560 Breast Cancer Samples
Jul 22, 2024, 07:34 PM
In a groundbreaking study published in Nature Communications, researchers identified three new distinct subtypes of Parkinson's Disease using AI. Additionally, a collaborative effort involving MIT, ETH Zurich, and other institutions utilized unsupervised AI to analyze chromatin images from 560 tissue samples of 122 patients. This research identified eight distinct cell states across all stages of ductal carcinoma in situ (DCIS), potentially improving the staging and treatment of breast cancer. The study, led by Caroline Uhler and Ph.D. student Xinyi Zhang, also highlighted the use of AI models to identify certain breast tumor stages likely to progress to invasive cancer.
View original story
Similar markets
Respiratory drug • 25%
Immunology drug • 25%
Vaccine • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Roche • 25%
Other • 25%
Alzheimer's Disease • 25%
Parkinson's Disease • 25%
Huntington's Disease • 25%
Other • 25%
Cancer • 25%
Cardiovascular disease • 25%
Neurological disorder • 25%
Other • 25%
Cancer • 25%
Autoimmune disorders • 25%
Infectious diseases • 25%
Other • 25%
Biogen • 25%
Roche • 25%
Pfizer • 25%
Other • 25%
Biogen • 25%
Roche • 25%
Novartis • 25%
Other • 25%
Cancer • 25%
Cardiovascular disease • 25%
Neurological disorder • 25%
Other • 25%
Depression treatment • 25%
Anxiety treatment • 25%
Bipolar disorder treatment • 25%
Other • 25%
Huntington's Disease • 25%
ALS • 25%
Duchenne Muscular Dystrophy • 25%
Other • 25%
Genetic Disorders • 25%
Infectious Diseases • 25%
Neurological Disorders • 25%
Other • 25%